* Institute of Histology and Embryology, Faculty of Medicine, University of Lisbon, 1699 Lisboa Codex, Portugal; and Howard
Hughes Medical Institute, Program in Molecular Medicine, University of Massachusetts Medical Center, Worcester,
Massachusetts 01605
U2AF65 is an essential splicing factor that promotes binding of U2 small nuclear (sn)RNP at the pre-mRNA branchpoint. Here we describe a novel monoclonal antibody that reacts specifically with U2AF65. Using this antibody, we show that U2AF65 is diffusely distributed in the nucleoplasm with additional concentration in nuclear speckles, which represent subnuclear compartments enriched in splicing snRNPs and other splicing factors. Furthermore, transient expression assays using epitope-tagged deletion mutants of U2AF65 indicate that targeting of the protein to nuclear speckles is not affected by removing either the RNA binding domain, the RS domain, or the region required for interaction with U2AF35. The association of U2AF65 with speckles persists during mitosis, when transcription and splicing are downregulated. Moreover, U2AF65 is localized to nuclear speckles in early G1 cells that were treated with transcription inhibitors during mitosis, suggesting that the localization of U2AF65 in speckles is independent of the presence of pre-mRNA in the nucleus, which is consistent with the idea that speckles represent storage sites for inactive splicing factors. After adenovirus infection, U2AF65 redistributes from the speckles and is prefferentially detected at sites of viral transcription. By combining adenoviral infection with transient expression of deletion mutants, we show a specific requirement of the RS domain for recruitment of U2AF65 to sites of active splicing in the nucleus. This suggests that interactions involving the RS region of U2AF65 may play an important role in targeting this protein to spliceosomes in vivo.
The splicing of intronic sequences from pre-mRNA
occurs within a multicomponent RNA-protein complex called the spliceosome (for review see Moore
et al., 1993 U2AF is an essential splicing factor required for binding
of U2 snRNP to the pre-mRNA branch point (Ruskin et al.,
1988 Although much is known about the biochemical details
of splicing in vitro, the organization of RNA processing in
the cell nucleus is only starting to be understood. Localization studies have shown that proteins involved in premRNA maturation tend to be heterogenously distributed
in the nucleus, suggesting that the processing reactions
might be compartmentalized in vivo (Carter et al., 1993 In addition to the widespread nucleoplasmic distribution, fluorescence confocal microscopy has revealed that
several constituents of the spliceosome appear concentrated in nuclear "speckles" or "foci," and at the electron
microscopic level these sites were shown to correspond to
clusters of interchromatin granules and coiled bodies, respectively (for review see Spector, 1993 In this report we describe a novel monoclonal antibody
that specifically reacts with U2AF65, and we show that this
protein colocalizes with splicing snRNPs and SR protein
splicing factors in nuclear speckles. We also present evidence that the association of U2AF65 with the nuclear
speckles is unrelated to splicing activity, consistent with
the idea that these structures represent a subnuclear compartment dedicated to storage or preassembly of the splicing machinery. Finally, the data indicate that the RS domain
of U2AF65 is required for recruitment to active splicing
sites in vivo.
Production of mAbs
Eight female BALB/c mice were immunized with purified recombinant
U2AF65 expressed in Escherichia coli. The protein was diluted with PBS to a concentration of 0.2 µg/ml, emulsified with Freund's adjuvant (Difco
Laboratories, Detroit, Michigan), and injected intraperitonially. Mice
were boosted twice at 3 wk intervals, and test bleeds were taken. The sera
were screened by ELISA and immunobloting using recombinant U2AF65
as antigen. The sera from all animals tested positive in these assays but
varied significantly in antibody titer. The spleen cells from the two mice
with higher antiserum titer were fused with Ag8.653 myeloma cells, and
hybrids were selected as described by Harlow and Lane (1988) Immunobloting, Immunodepletion, and
Complementation Assays
Total cell protein extracts were prepared by scraping the cells with a rubber policeman into SDS-PAGE sample buffer (62.5 mM Tris-HCl, pH 6.8, 2% SDS, 5% Immunodepletion of nuclear extracts was performed as follows: 100 µl
of protein A-agarose beads (Sigma Chemical Co.) were washed twice
with 500 µl of buffer D (20 mM Hepes, pH 8.0, 0.2 mM EDTA, 20% glycerol, 0.1M KCl, 1 mM DTT, 0.05% NP-40) on ice and incubated with 200 µl
of MC3 supernatant for 90 min at 4°C. After two washes in the same
buffer, the beads were added to 100 µl of nuclear extract (Dignam et al.,
1983 Cell Culture, Drug Treatment, and Viral Infection
HeLa cells were grown as monolayers in Dulbecco's modified minimum
essential medium supplemented with 10% fetal calf serum and maintained
mycoplasm free. Mitotic cells were isolated by the shake-off method, allowed to sediment by gravity for 1 h on ice, plated on glass coverslips, and
further incubated at 37°C for 50-60 min to obtain a population enriched in
late telophase/early G1 cells. For inhibition of transcriptional activity, cells
were treated for 1 to 2 h with either 5 µg/ml actinomycin D (Sigma Chemical Co.) or 75 µM DRB (5,6-dichloro-1- Transient Transfection Assays
The following primers were prepared. T8: 5 Immunofluorescence
For indirect immunofluorescence the cells were grown on 10 × 10-mm
glass coverslips and harvested at 60-80% confluency. Coverslips with attached cells were washed twice in PBS and treated according to the following alternative protocols: (a) immediate fixation with 3.7% formaldehyde (freshly prepared from paraformaldehyde) in PBS for 10 min at
room temperature and subsequent permeabilization with 0.5% Triton
X-100 in PBS for 15 min at room temperature; (b) permeabilization with
0.5% Triton X-100 in CSK buffer (Fey et al., 1986 In addition to the mAbs directed against U2AF65, the following antibodies were used in this study: human autoantiserum C45, specific for Sm
proteins (kindly provided by Professor W. van Venrooij, University of
Nijmegen, The Netherlands), mAb 3C5 directed against SR proteins
(Turner and Franchi., 1987; Bridge et al., 1995 In situ hybridization to detect poly A RNA was performed as described
(Carmo-Fonseca et al., 1992 Fluorescence and Confocal Microscopy
Samples were examined with a microscope (LSM 410; Zeiss, Inc.,
Oberkochen, Germany). Confocal microscopy was performed using argon
ion (488 nm) and HeNe (543 nm) lasers to excite FITC and Texas red fluorescence, respectively. For double labeling experiments, images from the
same focal plane were sequentially recorded and superimposed. To obtain
a precise alignment of superimposed images the equipment was calibrated
using multicolor fluorescent beads (Molecular Probes Inc., Eugene, OR)
and a dual-band filter that allows simultaneous visualization of red and
green fluorescence. The images were photographed on Fujichrome 100 or
Kodak TMax 100 film, using a freeze frame recorder (Polaroid Corp.,
Cambridge, MA). Alternatively, data files were directly printed on a digital printer (XLS 8300; Kodak Co., Rochester, NY).
Monoclonal Antibody MC3 Specifically
Recognizes U2AF 65
To obtain monoclonal antibodies, hybridomas were derived by fusion of the mouse myeloma cell line Ag8.653
with spleen cells from BALB/c mice immunized with recombinant U2AF65. Two clones, MC2 and MC3, tested
positive by ELISA using purified recombinant U2AF65 as
antigen. The antibody secreted by the MC2 clone is of the IgG1 class, and mAb MC3 is IgG2b. Immunoblot analysis
reveals that both mAbs recognize a single ~65-kD band in
HeLa protein extracts, that migrates with the same apparent molecular weight as the recombinant U2AF65 protein
used for immunizations (Fig. 1 A, and data not shown). Since the mAb MC3 reacts with U2AF65 with much higher
affinity than mAb MC2, it was chosen for further use.
Western blot analysis using a nuclear extract enriched in SR proteins (Zahler et al., 1992
As U2AF65 is an essential splicing factor, we tested mAb
MC3 for the ability to deplete splicing activity from nuclear extracts. Western blot analysis reveals that U2AF65 is
almost completely depleted from nuclear extracts incubated with mAb MC3 bound to protein A-agarose beads
(Fig. 1 B; the immunodepletion efficiency ranged between
90 and 99%). The depleted extracts do not support in vitro
splicing reactions, but splicing activity can be successfully
recovered by the addition of recombinant U2AF65 (Fig.
1 C). Although the incubation of nuclear extracts with mAb
MC3 results in depletion of both U2AF65 and U2AF35 (results not shown), addition of U2AF35 is not required to restore splicing activity, as previously described (Zamore
and Green, 1991 Using a series of GST-U2AF65 deletion mutants (Valcárcel et al., 1996
Subnuclear Localization of U2AF 65
Indirect immunofluorescence was performed using mAbs
MC2 and MC3. Both antibodies produced a diffuse staining of the nucleoplasm excluding the nucleoli, with additional concentration in 20-50 speckles (Fig. 3 A). These results were obtained in HeLa and Hep-2 cells as well as in
cryosections from rat brain tissue (data not shown). Similar results were observed when cultured cells were treated
with Triton X-100 either before or after fixation with formaldehyde or when the antibody was directly microinjected into the nuclei of living cells (Fig. 3 D). Double labeling experiments were performed using the mAb MC3
and either an anti-Sm antibody, which reacts with all splicing snRNPs (Baserga and Steitz, 1993
U2AF 65 Associates with Interchromatin Granules
during Mitosis
To investigate whether the presence of U2AF65 in nuclear
speckles is associated with splicing, we studied the distribution of U2AF65 during mitosis, when transcription and
hence splicing activities are inhibited (Prescott and Bender,
1962
U2AF 65 Associates with Speckles in the Absence of
Nuclear poly (A) RNA Synthesis
Having established that U2AF65 associates with interchromatin granules during mitosis when there is no transcriptional activity, we next asked whether U2AF65 can be targeted to nuclear speckles in the absence of poly (A) RNA
synthesis. Mitotic HeLa cells were treated with either 5 µg/ml actinomycin D or 75 µM DRB for 1 h to inhibit
transcriptional activity, and immunofluorescence was performed using the mAb MC3. In all early G1 cells observed,
the staining was concentrated in nuclear speckles, and
double labeling experiments using anti-Sm antibodies indicate that inhibition of transcription does not affect the
targeting of either U2AF65 or snRNPs to nuclear speckles
(Fig. 5, A-C). A parallel labeling of the cells with a mAb
for hnRNP A1 confirmed the efficiency of the transcription block, since transport of this protein into the nucleus
at the end of mitosis is transcription dependent (PiñolRoma and Dreyfuss, 1991). In addition, in situ hybridization experiments using a poly (U) oligonucleotide probe
fail to detect any poly (A) RNA signal in the nuclei of
early G1 cells treated with transcription inhibitors during
mitosis (Fig. 5, D-F). Taken together, these data suggest
that the localization of U2AF65 to nuclear speckles is unrelated to splicing activity.
The RS Region of U2AF 65 Is Not Required for
Targeting to Nuclear Speckles
Recently, Hedley et al. (1995)
The mAb 12CA5, which is specific for the HA tag, produces a faint background staining on untransfected HeLa
cells or on cells transfected with the vector alone (data not
shown). When cells are transfected with either epitopetagged recombinant U2AF65 (U2AF65WT-T) or either of the
deletion mutants, the mAb 12CA5 displays an intense
staining of the nucleus (Fig. 7). At higher magnification the
nuclear staining pattern is clearly speckled, similar to that observed with mAb MC3 (Figs. 3 A and 8 A). Double labeling of the transfected cells with mAb 12CA5 and anti-Sm
antibodies show that U2AF65WT-T colocalizes with splicing snRNPs in nuclear speckles but not in coiled bodies
(Fig. 8, A and E, and data not shown). Interestingly, the
deletion mutants U2AF65
The RS Region of U2AF65 Is Involved in Recruitment to
Splicing Sites
Since the presence of U2AF65 in nuclear speckles appears
to be unrelated to splicing activity, we tried to visualize the
recruitment of this protein to active splicing sites within
the nucleus. For this we have made use of adenovirus infection, because this virus subverts the normal nuclear organization by recruiting the host transcription and processing machinery to the sites of viral mRNA synthesis
(Jiménez-Garcia and Spector, 1993
Consistent with the idea that upon viral infection,
U2AF65 is recruited from the nuclear speckles to ring-like
structures that represent sites of active viral RNA transcription and processing, treatment of cells infected with
adenovirus for 14-16 h with transcription inhibitors such
as actinomycin D or DRB induces a relocalization of
U2AF65 into speckles (Fig. 10, A and D, B and E). After
removal of DRB, U2AF65 is again detected in ring-like
structures associated with the viral genomes (Fig. 10, C
and F), similar to the pattern observed in untreated cells
(Figs. 10 C and 9, B and F).
To test whether any of the major functional domains of
U2AF65 is required for targeting the protein to viral splicing sites, HeLa cells were transfected with either
U2AF65
In conclusion, the data suggest that the RS domain of
U2AF65 may play an important role in targeting the protein to sites of active transcription and splicing in vivo.
In this study we show that a novel monoclonal antibody
specific for the splicing factor U2AF65 produces a diffuse
staining throughout the nucleoplasm with additional concentration in nuclear speckles, and a similar distribution pattern is observed in cells transiently transfected with
epitope-tagged recombinant U2AF65. This makes it likely
that U2AF65 is localized to nuclear speckles.
Within the nucleus, U2AF65 is shown to colocalize with
splicing snRNPs and SR protein splicing factors in speckles that correspond to clusters of interchromatin granules
at the electron microscopic level. Since these clusters also
contain poly (A) RNA (Carter et al., 1991 Although U2AF65 colocalizes with SR protein splicing
factors in nuclear speckles, there are some differences in
the subnuclear distribution of these two types of proteins.
First, during interphase, U2AF65 is clearly widespread in
the nucleoplasm with additional concentration in speckles,
whereas SR proteins are predominantly detected in speckles. Second, at the end of mitosis, U2AF65 is rapidly imported into the daughter cell nuclei, while SR proteins remain concentrated in large cytoplasmic speckles for a
longer period of time. Thus, the intracellular dynamics of
U2AF65 appear to be more similar to snRNPs than to SR
proteins, and this discrepancy may be related to the structural and functional differences between U2AF65 and SR
proteins. In fact, U2AF65 binds to the polypyrimidine tract
of pre-mRNA and promotes binding of U2 snRNP to the
branchpoint (Ruskin et al., 1988 In addition to U2AF65, U2AF35, and SR protein splicing
factors, RS domains are also present in other proteins involved in splicing. These include the U1 snRNP 70-kD
protein and the Drosophila splicing regulators suppressor
of white-apricot, Transformer (Tra), and Transformer 2 (Tra 2). Significantly, all of these proteins localize to nuclear speckles in mammalian cells (Verheijen et al., 1986 In addition to the repeating RS dipeptides and a stretch
of basic amino acids, the RS region of U2AF65 contains a
potential nuclear localization signal (Fig. 6), and therefore
one might expect that the deletion mutant U2AF65 Previous studies have demonstrated that adenovirus
subverts the normal organization of splicing factors in the
mammalian cell nucleus, although different patterns of
distribution have been described depending on the infection stage. When infected cells are treated with a DNA
synthesis inhibitor to block viral replication (Zhang et al.,
1994). The major subunits of the spliceosome are the
U1, U2, U4/U6, and U5 small nuclear (sn)1 RNPs (for review see Baserga and Steitz, 1993
). In addition, spliceosomes contain a group of non-snRNP protein splicing factors, several of which have been purified and cloned (for
review see Krämer, 1996
). In mammalian cells, the best
characterized are U2AF (U2 snRNP auxiliary splicing factor), ASF/SF2 (alternative splicing factor/splicing factor
2), and SC-35 (35-kD spliceosomal component). Sequence
comparison revealed that these three factors have a common basic structure that can be divided into two functional subdomains: a consensus type RNA binding domain and a
region of arginine/serine (RS) repeats. The RNA-binding
domain consists of one or more RNP consensus motifs
(RNP-CS) that are required for high affinity and sequence-specific binding of the proteins to RNA (Burd and
Dreyfuss, 1994
). The RS motif consists of either an uninterrupted stretch of arginine/serine dipeptides or a more dispersed RS-rich region (for review see Lamm and Lamond, 1993
). Interestingly, a single monoclonal antibody
reacts with a family of at least six RS-rich splicing proteins,
including ASF/SF2 and SC-35 (Zahler et al., 1992
). The
members of this family are commonly referred to as SR
protein splicing factors and are highly conserved between
Drosophila and humans (Mayeda et al., 1992
; Zahler et al.,
1992
). These proteins have been shown to be required for spliceosome assembly as well as for the first step of the
splicing reaction, and more recent evidence indicates that
they are also implicated in splice site selection and regulated alternative splicing (Wu and Maniatis, 1993
; Kohtz
et al., 1994
).
; Zamore and Green, 1989
). It is composed of two
subunits, U2AF65 and U2AF35 (Zamore et al., 1992
; Zhang
et al., 1992
). While the 65-kD subunit alone is sufficient to
reconstitute the in vitro splicing activity of nuclear extracts
that have been depleted of U2AF by chromatography on
poly (U) Sepharose (Zamore and Green, 1991
; Zamore et
al., 1992
; Valcárcel et al., 1993
, 1996), a requirement for
U2AF35 has been documented genetically (Rudner et al.,
1996
) and biochemically using immunodepleted extracts
(Zuo and Maniatis, 1996
). The RNA binding domain of
U2AF65 contains three RNP consensus sequence motifs
that specifically bind to the polypyrimidine tract adjacent
to the 3
splice site (Zamore et al., 1992
; Valcárcel et al.,
1993
; Singh et al., 1995
). The RS domain is located at the
NH2-terminus of the protein and promotes the annealing
of U2 snRNA to the pre-mRNA branchpoint (Valcárcel et
al., 1996
).
).
Early electron microscopic studies have clearly established
that RNA-protein complexes in the nucleus are localized to distinct types of structures, namely the nucleolus, the
perichromatin fibrils, the clusters of interchromatin granules, and the coiled body (for review see Monneron and
Bernhard, 1969
). Electron microscopic autoradiography
has further demonstrated that extranucleolar RNA synthesis occurs in association with perichromatin fibrils, and the more recent techniques of immunoelectron microscopy have shown that several components of the premRNA splicing machinery are associated with perichromatin fibrils (for review see Fakan, 1994
). Thus, it is likely
that these fibrils represent nascent transcripts with associated spliceosomes. At the light microscopic level it is not
possible to resolve perichromatin fibrils, and when immunofluorescence is performed using antibodies that label
perichromatin fibrils (for example, antibodies to snRNP or
heterogeneous nuclear [hn]RNP proteins), the staining is
diffuse in the nucleus, excluding the nucleolus. As perichromatin fibrils are present throughout the nucleoplasm,
it is conceivable that the diffuse fluorescent signal represents labeling associated with these fibrils. However, since sn- and hnRNPs are very abundant nuclear components
(Rosbash and Singer, 1993
; Kiledjian et al., 1994
), it is also
possible that a pool of excess proteins contributes to the
diffuse labeling pattern observed.
). Studies from several laboratories indicate that each of the spliceosomal snRNPs is present widespread in distribution in the nucleoplasm, with an additional concentration in both clusters
of interchromatin granules and coiled bodies (for review
see Bohmann et al., 1995a
), whereas SR protein splicing
factors are predominantly detected in speckles (i.e., clusters of interchromatin granules; Fu and Maniatis, 1990
;
Spector et al., 1991
). In contrast, U2AF was described as
diffusely distributed in the nucleoplasm with additional
concentration in coiled bodies (Carmo-Fonseca et al.,
1991
; Zamore and Green, 1991
; Zhang et al., 1992
). However, more recent evidence indicates that the RS domain
of the Drosophila splicing protein Tra contains a sequence
that can function both as a nuclear localization signal and
a speckle localization signal (Hedley et al., 1995
). As a similar amino acid sequence motif is found in the RS region of U2AF65, this protein should also localize to nuclear
speckles.
Materials and Methods
. After 10 d,
hybridoma supernatants were tested for reactivity with recombinant
U2AF65 by ELISA. Of 480 fusion wells, 3 tested positive and 2 (MC2 and MC3) were successfully cloned by limiting dilution on microtiter plates.
The two hybridoma cell lines were used to induce a peritoneal tumor in
pristane primed adult female mice, and ascitic fluid was collected (Harlow
and Lane, 1988
). The antibody subtypes were determined using a kit from
Boehringer Mannheim GmbH (Mannheim, Germany).
-mercaptoethanol, 10% glycerol, and 0.01% bromophenol
blue) with 200 U/ml benzonase (Sigma Chemical Co., St. Louis, MO), incubating for 15 min at room temperature (to digest DNA), and then boiling for 5 min. The SR protein extract was prepared as described by Zahler
et al. (1992)
. Drosophila and Xenopus protein extracts were prepared
from SL2 and MCM cells, respectively. Proteins were separated on either
8 or 12% acrylamide gels and transferred to nitrocellulose membranes using a semi-dry electrotransfer apparatus (BioRad Laboratories, Richmond, California). The membranes were blocked and washed with 2%
nonfat milk powder in PBS. The blots were incubated for 1 h with hybridoma supernatant diluted in washing buffer, washed, and incubated for 1 h
with secondary antibody conjugated to alkaline phosphatase (BioRad Laboratories).
) and incubated for 3 h at 4°C. The depleted extract was collected by
centrifugation. For the complementation assays, splicing reactions were
performed with 10 fmoles of an adeno major late promoter-derived premRNA substrate, 22% HeLa nuclear extract (either complete or MC3depleted), 3.3% polyvinyl alcohol, 1.67 mM MgCl2, 25 mM KCl, 1 mM
ATP, 22 mM creatine phosphate, in the presence or absence of 12.5 ng/µl of recombinant purified GST-U2AF65 protein, for 2 h at 30°C. After proteinase K, phenol extraction, and precipitation, the products of the splicing reaction were analyzed by PAGE on a 13% gel.
-d-ribofuranosylbenzimidazole; Sigma Chemical Co.). Reversal of the DRB transcription block was made
by washing the cells three times with fresh medium and allowing them to
recover for 1 h at 37°C. Infection of HeLa cells with adenovirus type 2 (Ad2) was performed as described (Pombo et al., 1994
).
-CCGGTACCGACACCATGTACGACTACGTCCCTGATTAG CAATGTCGGACTTCGAC-3
. T9:
5
-GGACGCGTCTACCAGAAGTCCCGGCGGTG-3
. T10: 5
-GGACGCGTCTACTTGTGGGCAGAGTCGGG-3
. NLR1: 5
-CTCGTGGAGGGGGGAACGAATCAG-3
. RK36: 5
-CTCTACGTGGGCAACATCCCC-3
. RK38: 5
-CTGTTCA TCGGGGGCTTACCC-3
. Primer T8 was
designed to encode a 10 amino acid hemagglutinin (HA) epitope tag to
distinguish the transiently expressed protein from the endogenous protein. Templates for PCR were as described by Zamore et al. (1992)
. HAtagged U2AF65WT and U2AF65
RS cDNAs were prepared using primers
T8 and T9. U2AF65
RNP2,3 was prepared using primers T8 and T10.
U2AF65
84-150 and U2AF65
84-260 were prepared using pECEU2AF65-T (Zamore et al., 1992
) and primers NLR1/RK36 and NLR1/
RK38, respectively. PCR was carried out under the following conditions: 94°C for 30 s, 64°C for 30 s, and 72°C for 3 min. Upon completion of the 30 cycles, an additional elongation step was carried out for 7 min at 72°C. The
products and the expression vector CMV5 (see Andersson et al., 1989
;
kindly provided by Dr. Maria Zapp, University of Massachusetts Medical
Center, Worcester, MA) were cut with KpnI and MluI for ligation. The ligated product was transformed into DH5
. DNA sequence analysis was
performed to determine if the clones contained the correct deletions.
DNA constructs were transiently transfected into cells, and Western blot
analysis was performed using anti-HA antibodies to determine if the constructs were being expressed (data not shown). Transient transfection of
HeLa cells was performed using Lipofectin (GIBCO BRL, Gaithersburg, MD), according to the manufacturer's instructions. Approximately 2 µg of DNA was used per assay. The cells were analyzed by immunofluorescence at 24 to 48 h after transfection.
) containing 0.1 mM
PMSF for 1 min on ice and subsequent fixation with 3.7% formaldehyde
in CSK for 10 min at room temperature. After fixation and permeabilization, the cells were rinsed in PBS containing 0.05% Tween 20 (PBS-T), incubated for 1 h with primary antibodies diluted in PBS-T, washed, and incubated for 30 min with the appropriate secondary antibodies conjugated
to either fluorescein or Texas red (Dianova GmbH, Hamburg, Germany; Vector Laboratories, Peterborough, UK). Finally, the coverslips were
mounted in VectaShield (Vector Laboratories) and sealed with nail polish.
), rabbit polyclonal serum
204.4 directed against the coiled body protein p80-coilin (Bohmann et al.,
1995b
), rabbit polyclonal serum directed against the adenoviral protein
DBP (Linné et al., 1977
), mAb 4B10 specific for hnRNP protein A1
(Piñol-Roma et al., 1988
), and mAb 12CA5-I directed against the HA
epitope (Berkeley Antibody Company, Richmond, CA). Note that double
labeling with the mAbs 3C5 and MC3 was possible because 3C5 is an IgM
and MC3 is an IgG. To control the specificity of the secondary antibodies, the cells were incubated with each primary antibody alone and then incubated alternatively with either anti-IgM or anti-IgG conjugates.
) using a biotinylated 2
-O-methyl oligoribonucleotide probe (Sproat et al., 1989
) containing 20 tandem uridine residues. Detection of adenoviral RNA was performed as described (Pombo
et al., 1994
).
Results
) shows that mAb MC3
does not crossreact with the SR family of protein splicing
factors (Fig. 1 A). The mAb MC3 recognized a ~65-kD
protein from Xenopus but failed to react with Drosophila
protein extracts (results not shown).
Fig. 1.
The mAb MC3 reacts specifically with U2AF65. (A) Immunoblot analysis was performed using MC3 hybridoma supernatant diluted 1:100. A 12% acrylamide gel was loaded with total
protein extract from HeLa cells (1-4 × 105 cells/well), SR protein-enriched fraction (10 µg/well), and purified recombinant
U2AF65 (0.2 µg/well). Molecular weight markers are indicated on
the left. (B) Immunoblot analysis of nuclear extracts (1, 2, or 5 µl
per lane, as indicated). NE, control nuclear extract; NE, nuclear
extract immunodepleted using mAb MC3. (C) In vitro reconstitution/splicing reactions were performed using nuclear extract
(control), U2AF65-immunodepleted extract (
NE), or U2AF65immunodepleted extract plus 12.5 ng/µl of purified recombinant U2AF65 (rNE).
[View Larger Version of this Image (28K GIF file)]
).
), we conclude that the epitope recognized by mAb MC3 maps between amino acids 138 and
161 (Fig. 2).
Fig. 2.
Epitope mapping of U2AF65. (A) Diagram showing the
reactivity of mAb MC3 with different GST-U2AF65 fusion proteins as determined by immunoblot analysis. The grey bars represent the U2AF65 fragment fused to the GST protein. Hatched regions represent internal deletions of U2AF65. (B) Diagram
showing the mapped epitope (amino acids 138-161, bar) in relation to the functional organization of U2AF65. The mapped region overlaps with the beginning of the RNA binding domain
(amino acids 151-462).
[View Larger Version of this Image (25K GIF file)]
), mAb 3C5, which
recognizes SR protein splicing factors (Bridge et al., 1995
)
and labels clusters of interchromatin granules by immunoelectron microscopy (Turner and Franchi, 1987
), or an
anti-coilin antibody to label coiled bodies (Bohmann et al.,
1995b
). The results show that U2AF65 colocalizes with snRNPs and SR proteins in nuclear speckles (Fig. 3, B and C,
and data not shown), but labeling of coiled bodies was
never detected (Fig. 3, D and E, and data not shown). This contrasts with the results previously obtained using a purified polyclonal antibody raised against a synthetic peptide
of U2AF65, which produced a predominantly diffuse nucleoplasmic staining with additional concentration in coiled bodies (Carmo-Fonseca et al., 1991
; Zamore and Green,
1991
). In this regard it is noteworthy that when the mAb
MC3 is used at high dilutions it also produces a predominantly diffuse staining pattern. This argues that the failure
to detect speckles previously could have been due to a low
titer of the anti-peptide antibody. Furthermore, when cells are treated with actinomycin D for 1-2 h, U2AF65 is detected both in enlarged speckles and in perinucleolar
patches (Fig. 3 F, arrowheads, and G). As a similar perinucleolar staining was previously observed (Carmo-Fonseca
et al., 1991
), this suggests that in vivo the antipeptide antibody reacts preferentially with a subfraction of the total
U2AF65 in the nucleus. In contrast, the reason for the differential recognition of coiled body epitopes in vivo by
these two antibodies remains to be elucidated. Clearly,
there are peculiar properties of the epitopes recognized by
the distinct antibodies, and to solve this discrepancy we
have analyzed the distribution of epitope-tagged U2AF65
in transiently transfected HeLa cells. The results observed
are identical to those revealed by the new monoclonal antibodies (Figs. 3 A and 8 A), allowing us to settle the controversy.
Fig. 3.
Subnuclear localization of U2AF65. (A) HeLa cells
were fixed with formaldehyde, permeabilized with Triton X-100,
and incubated with mAb MC3 (hybridoma supernatant undiluted). (B and C) HeLa cells were permeabilized with Triton
X-100 before fixation. Double labeling was then performed using
mAb MC3 (B) and mAb 3C5 (C). (D and E) Living HeLa cells
were microinjected in the nucleus with MC3 ascitic fluid and further incubated at 37°C for 30 min. Then, the cells were fixed in
formaldehyde, permeabilized with Triton X-100, and sequentially
incubated with anti-coilin rabbit polyclonal antibody, anti-rabbit
IgG coupled to Texas red (E), and anti-mouse IgG coupled to
FITC (D). In D, arrowheads indicate the position of coiled bodies as observed on overlays of both fluorescence signals. The cells
depicted in panels F and G were incubated with 5 µg/ml actinomycin D for 2 h, permeabilized with Triton X-100, fixed in formaldehyde, and double labeled with MC3 (F) and anti-Sm antibodies (G). Arrowheads in F indicate staining of perinucleolar
structures. Bars, 10 µm.
[View Larger Version of this Image (52K GIF file)]
Fig. 8.
Epitope-tagged recombinant U2AF is targeted to nuclear speckles. HeLa cells were transfected with either U2AF65-T (A and
E), U2AF65RNP2,3-T (B and F), U2AF65
RS-T (C and G), or U2AF65
84-150-T (D and H). Cells were fixed at 24 to 36 h after transfection, and the ectopically expressed protein was detected using mAb 12CA5 directed against the HA tag. Double labeling experiments were performed using mAb 12CA5 (A-D) and anti-Sm antibody (E-H). An arrow in G indicates a coiled body that is stained by
anti-Sm antibody but not by mAb 12CA5. Cells depicted in A-C and E-G were permeabilized with Triton X-100 before fixation,
whereas the cells depicted in D and H were first fixed with formaldehyde and then permeabilized with Triton X-100. Extraction with detergent before fixation significantly enhanced the speckled staining pattern. To ensure that U2AF was also detected in speckles when
cells were first fixed and then extracted with detergent, some samples were treated with actinomycin D for 1 h before fixation (D and
H). As previously demonstrated for other splicing factors, actinomycin D induces an accumulation of U2AF65 in enlarged, rounded up
speckles. Bar, 10 µm.
[View Larger Version of this Image (61K GIF file)]
). From metaphase through telophase the mAb MC3
produces a diffuse staining of the cell excluding the chromosomes, with additional concentration in speckled structures (Fig. 4, A-C). Double labeling experiments using the mAb MC3 and anti-Sm antibody (Fig. 4, D-L) or the mAb
3C5 (data not shown) indicate that U2AF65 colocalizes
with snRNPs and SR proteins in mitotic speckles that correspond to mitotic clusters of interchromatin granules
(MIGs; Ferreira et al., 1994
). In contrast, a colocalization
of U2AF65 with mitotic coiled bodies was never detected.
The association of U2AF65 with mitotic speckles is most
prominent during telophase, when the number and size of
MIGs is higher (Ferreira et al., 1994
). In late telophase/
early G1 cells, U2AF65 and snRNPs are predominantly detected within the nuclei of daughter cells, whereas the
mAb 3C5 labels large speckles that persist in the cytoplasm (Fig. 4, M-O). This suggests that at the end of mitosis, U2AF65 and snRNPs leave the MIGs and are rapidly
transported into the daughter cell nuclei, whereas SR proteins remain associated with MIGs in the cytoplasm for a
longer period of time.
Fig. 4.
Intracellular distribution of
U2AF65 during mitosis. HeLa cells were
fixed with formaldehyde, permeabilized
with Triton X-100, and incubated with
mAb MC3 (A-C) or double-labeled with
mAb MC3 and anti-Sm antibody (D-L).
From metaphase to telophase, the staining produced by mAb MC3 is diffuse in
the cytoplasm, excluding the chromosomes, with additional concentration in
speckles (A-C, arrowheads). During the
early stages of telophase, both U2AF
and snRNPs colocalize in mitotic speckles and are excluded from the newly
forming nucleus (D-F). As telophase
proceeds, U2AF and snRNPs are simultaneously detected in mitotic speckles
(arrowheads) and within the daughter cell nuclei (G-I), whereas in early G1
cells, U2AF and snRNPs are exclusively
detected in the nucleus (J-L). For double labeling experiments using mAbs
MC3 and 3C5, the cells were extracted
with Triton X-100 before formaldehyde
fixation (M-O). These experiments show that in late telophase cells, SR proteins persist associated with mitotic
speckles (N, arrowheads), while U2AF is
predominantly localized to the nucleus
(M). Inspection of cells at earlier stages of telophase confirm the presence of
U2AF in mitotic speckles in these preparations, indicating that this lack of colocalization between U2AF and SR proteins is not an artifact induced by the preextraction procedure. Bar, 10 µm.
[View Larger Version of this Image (81K GIF file)]
Fig. 5.
U2AF 65 associates
with nuclear speckles in the
absence of RNA synthesis.
Mitotic HeLa cells were
treated with 5 µg/ml actinomycin D for 1 h, and then
double immunofluorescence
was performed using mAb
MC3 and anti-Sm antibody.
The labeling produced by
both antibodies is clearly
concentrated in nuclear
speckles (A-C). A similar experiment was performed
with the transcription inhibitor DRB; then, the cells were
hybridized in situ with a poly
(U) riboprobe and immunolabeled with anti-Sm antibody. No poly (A) RNA is
detected in the nucleus, while snRNPs are clearly
concentrated in nuclear
speckles (D-F). Bar, 10 µm.
[View Larger Version of this Image (91K GIF file)]
identified an amino acid sequence within the RS region of the Drosophila protein Tra
that is sufficient to target an heterologous protein to nuclear speckles. Since a similar sequence motif (i.e., a stretch
of basic amino acids followed by RS dipeptides and a putative bipartite NLS) is present in the RS region of U2AF65
(Fig. 6 A), we decided to study the role of the U2AF65 RS
region in subnuclear localization. Transient transfection assays were performed on HeLa cells using the pCMV5
expression vector (Andersson et al., 1989
). The vector contained a 10 amino acid influenza HA epitope tag cloned
in frame in front of the cDNA coding for U2AF65. Four
deletion mutants were analyzed: U2AF65
RS-T has a deletion of amino acids 23-65, covering all the RS domain;
U2AF65
RNP2,3-T has a deletion of amino acids 260-475,
spanning the RNA binding regions RNP2 and RNP3;
U2AF65
84-150-T has a deletion of amino acids 84-150,
covering the region of interaction with U2AF35; and
U2AF65
84-260-T has a deletion of amino acids 84-260
spanning both the region of interaction with U2AF35 and
the RNP1 domain (Fig. 6 B).
Fig. 6.
Both U2AF65 and U2AF35 contain putative "speckle localization signals." (A) Diagram showing the putative speckle localization signal of the Drosophila melanogaster splicing factor
Tra, identified by Hedley et al. (1995) and similar sequence motifs present in U2AF65 and U2AF35 that may represent potential
nuclear and subnuclear localization signals. Shown is the amino
acid sequence of the SR domain of both proteins. Sequences containing three or four basic residues directly adjacent to RS dipeptides are boxed. Putative nucleoplasmin-like NLSs are indicated.
(B) A diagram of the constructs used for transfection is shown:
, HA-tag; 35, binding region for U2AF35.
[View Larger Version of this Image (33K GIF file)]
RS-T, U2AF65
RNP2,3-T,
U2AF65
84-150-T, and U2AF65
84-260-T retained the ability to localize to nuclear speckles (Fig. 8, B and F, C and
G, D and H, and data not shown). Thus, neither of these
domains of U2AF65 on its own is essential to target the
protein to nuclear speckles.
Fig. 7.
Epitope-tagged recombinant U2AF is targeted to the
nucleus. HeLa cells were transfected with the pCMV5 expression
vector containing a 10-amino acid influenza HA epitope tag
cloned in frame in front of the cDNA coding for either U2AF65
(A), U2AF65RNP2,3 (B), U2AF65
RS (C), or U2AF65
84-150
(D). At 24 to 36 h after transfection the cells were fixed with
formaldehyde and permeabilized with Triton X-100, and the ectopically expressed protein was detected using mAb 12CA5 directed against the HA tag. Bars, 10 µm.
[View Larger Version of this Image (88K GIF file)]
; Pombo et al., 1994
). When adenovirus-infected HeLa cells are probed with
mAb MC3, the nuclear staining pattern changes significantly depending on the stage of infection. During the
early phase of infection (i.e., before the onset of major viral DNA replication, which occurs at ~8 h after infection),
U2AF65 is detected in speckles, similar to that observed in
noninfected cells (data not shown). After the onset of viral
replication the normal nuclear architecture is grossly
changed, and U2AF65 is no longer observed in speckles.
Rather, in cells infected for 14-18 h the U2AF65 staining is
predominantly detected in ring-like structures that surround the sites of viral DNA labeled with an antibody directed against the adenovirus DNA binding protein, DBP.
As we had previously shown that adenovirus induces a redistribution of splicing snRNPs into ring-like structures
that colocalize with the sites of viral transcription (Pombo
et al., 1994
), double labeling experiments were performed
using mAb MC3 and anti-Sm antibodies. The results indicate that U2AF65 colocalizes with snRNPs in the ringlike structures (Fig. 9, A-D), and similar results are observed on cells that were sequentially transfected with
U2AF65WT-T, infected with adenovirus, and probed with
anti-tag antibody (Fig. 9, E and F). Thus, we conclude that
the ring structures labeled by MC3 and anti-tag antibody
correspond to U2AF65 at sites of active splicing. At later
stages of infection (20-24 h after infection), the ring-like
structures become less prominent, and U2AF65 is predominantly observed in enlarged speckles that also contain splicing snRNPs, SR protein splicing factors, and viral
RNA (data not shown; see Bridge et al., 1996
).
Fig. 9.
Adenovirus induces a redistribution of U2AF65 in the
nucleus of infected cells. HeLa cells were either mock infected
(A, C, and E) or infected with Ad2 for 18 h, at a multiplicity of infection of 20 focus forming units per cell (B, D, and F). The cells
were permeabilized with Triton X-100, fixed with formaldehyde,
and double labeled using mAb MC3 and anti-Sm antibody (A
and C, B and D). Alternatively, cells were first transfected with
U2AF65WT-T and then were either mock infected or infected
with Ad2 (E and F). The ectopically expressed protein was detected using mAb 12CA5. Note that in uninfected cells, all antibodies produce a speckled staining of the nucleoplasm (A, C, and
E), whereas after infection the staining is concentrated in ringlike structures (B, D, and F). Bar, 10 µm.
[View Larger Version of this Image (76K GIF file)]
Fig. 10.
U2AF65 relocalizes to speckles upon inhibition of adenoviral transcription. HeLa cells were
transiently transfected with
HA-tagged U2AF65 for 24 h
and then infected with Ad2.
At 14 h after infection the
cells were treated with either
5 µg/ml actinomycin D (A
and D) or 75 µM DRB for 1 h
(B and E). After DRB treatment, the drug was removed
from the culture medium,
and the cells were allowed to
recover for 1 h (C and F). A-C
depict U2AF65 labeling using an anti-tag antibody
(mAb 12C5), and panels D-F depict the sites of viral genome accumulation using an
antibody directed against
the viral DNA binding protein DBP. Arrowheads point
to the localization of viral
centers. Bar, 10 µm.
[View Larger Version of this Image (74K GIF file)]
RS-T, U2AF65
RNP2,3-T, U2AF65
84-150-T, or
U2AF65
84-260-T and then infected with adenovirus (Fig.
11). The ectopically expressed proteins were detected using the anti-tag mAb 12CA5, and the viral genomes were
visualized using a polyclonal antibody specific for the DBP
as previously described (Pombo et al., 1994
). The results
confirm that U2AF65WT-T concentrates around the sites
of viral genome accumulation (Fig. 11, A and D). Unexpectedly, the deletion mutant U2AF65
RNP2,3-T, which
does not bind to pre-mRNA in vitro (Zamore et al., 1992
),
is also redistributed to the sites of viral genome accumulation and transcription (Fig. 11, B and E), indicating that binding of U2AF65 to pre-mRNA is not essential to recruit
the protein to splicing sites in vivo, and similar results were
observed with U2AF65
84-150-T (Fig. 11, C and F) and
U2AF65
84-260-T (data not shown). In contrast, the deletion mutant U2AF65
RS-T fails to concentrate in the typical ringstructures (Fig. 11, G and J). As the U2AF65 RS region is essential for splicing (Zamore et al., 1992
; Valcárcel et al., 1996
), expression of the U2AF65
RS-T construct
could exert a dominant negative effect and therefore inhibit splicing in these cells. Consequently, the absence of ring structures could reflect a block in splicing activity. To address this point, cells were transfected with U2AF65
RS-T,
infected with adenovirus, and double labeled with anti-tag and anti-Sm antibodies (Fig. 11, H and K). As depicted in
Fig. 11 K, Sm proteins are localized in ring structures, indicating that expression of the U2AF65
RS-T construct does
not prevent recruitment of splicing snRNPs to the sites of
viral RNA synthesis. Furthermore, cells that express the
U2AF65
RS-T construct are shown to contain spliced viral
RNA in both the nucleus and the cytoplasm (Fig. 11, I and
L, and data not shown). This implies that normal processing/transport of adenoviral RNA is taking place in these
cells.
Fig. 11.
Recruitment of
U2AF65 to adenoviral splicing sites. HeLa cells were
transiently transfected with
either U2AF65WT-T (A and
D), U2AF65RNP2,3-T (B
and E), U2AF65
84-150-T (C
and F), or U2AF65
RS-T
(G-L) for 24-48 h and then
infected with Ad2 and harvested at 18 h after infection.
The cells were permeabilized
with Triton X-100, fixed with
formaldehyde, and double labeled using mAb 12C5 (A-C
and G) and a rabbit polyclonal
antibody directed against the viral DNA binding protein DBP (D-F and J). Alternatively, the cells were double labeled with mAb 12C5
and anti-Sm antibody (H and
K). The cells depicted in I
and L were labeled with
mAb 12C5, digested with
DNaseI, and hybridized
with an Ad2 genomic probe
to detect viral RNA as previously described (Pombo et
al., 1994
). Note that cells expressing U2AF65
RS contain
viral RNA in both the nucleus and the cytoplasm (arrowheads); the arrow indicates a nontransfected cell.
Similar results were observed
in cells hybridized with a splice
junction oligonucleotide probe
(Bridge et al., 1996
) to detect
spliced Ad2 RNA (not
shown). Bars, 10 µm.
[View Larger Version of this Image (116K GIF file)]
Discussion
; Visa et al., 1993
),
the presence of splicing factors in these structures has
been thought to represent a subnuclear compartmentalization of spliceosomes assembled on pre-mRNA (Carter et al.,
1993
). However, the findings that splicing occurs co-transcriptionally (Beyer and Osheim, 1988
; LeMaire and Thummel, 1990
; Bauren and Wieslander, 1994
) and that there is
no transcriptional activity in clusters of interchromatin
granules (Fakan, 1994
) argue against the idea that speckles
represent splicing sites. Alternatively, clusters of interchromatin granules may be implicated in storage or preassembly of the splicing machinery (Spector, 1993
; Zhang et al., 1994
). Here we present further evidence consistent
with this view. First, U2AF65 is concentrated in interchromatin granules during mitosis when transcription and
splicing are downregulated. Second, at the end of mitosis,
U2AF65 is targeted to clusters of interchromatin granules
in the absence of newly synthesised poly (A) RNA in the
nucleus. Finally, the deletion mutant U2AF65
RS, which
fails to be recruited to active splicing sites, maintains the
ability to localize in nuclear speckles.
; Zamore and Green, 1989
),
whereas SR protein splicing factors are implicated in 5
and 3
splice site selection (Fu and Maniatis, 1992
; Zahler et al., 1992
; Wu and Maniatis, 1993
). Particularly, the RS
region of U2AF65 promotes a base-pairing interaction between U2 snRNA and the pre-mRNA (Valcárcel et al.,
1996
), while the RS domains of SR protein splicing factors
mediate protein-protein interactions in the spliceosome
(Wu and Maniatis, 1993
; Amrein et al., 1994
; Kohtz et al.,
1994
).
; Li and Bingham, 1991
; Hedley et al., 1995
), and recent evidence indicates that an amino acid sequence within the RS
domain of the Drosophila Tra protein is sufficient for targeting an heterologous protein to nuclear speckles (Li and
Bingham, 1991
; Hedley et al., 1995
). Like Tra, U2AF65 contains an RS domain with a stretch of basic amino acids followed by RS dipeptides and a putative bipartite NLS (Fig.
6 A), and we show here that it is also present in nuclear
speckles. However, our results further indicate that the intranuclear distribution of the protein is not affected by deletion of the RS domain. In this regard, it is important to
note that a Tra deletion mutant lacking the "speckle localization signal" has also been shown to localize to speckles,
presumably through interactions with another protein
(Tra 2) that contains the signal (Hedley et al., 1995
). Thus,
it is conceivable that protein-protein interactions may
be responsible for targeting the U2AF65
RS mutant to the
speckles, and a potential candidate is U2AF35. In fact,
the RS domain of U2AF35 may also contain a putative
"speckle localization signal" (Fig. 6 A), and it binds to a
region of U2AF65 that is conserved in U2AF65
RS. Interestingly, deletion of the U2AF65 region that interacts with
U2AF35 also does not affect targeting to the speckles, indicating that this part of the protein is not essential for the
subnuclear localization of U2AF65. However, it remains
possible that either the presence of an RS domain in the
protein or interaction with U2AF35 may be sufficient to
target U2AF65 to the speckles, and further mutagenesis
work is currently in progress to address this question.
Also, more immunolocalization studies are necessary to
clarify the subnuclear distribution of U2AF35 since previous reports have failed to detect this protein in speckles
(Zhang et al., 1992
).
RS
would not be transported into the nucleus. Our observation that this mutant is present in the nucleus and localizes
to speckles raises the possibility that protein-protein interactions may play an important role in both nuclear and
subnuclear localization of U2AF, as recently pointed out
by Hedley et al. (1995)
for other splicing proteins.
) or in cells analyzed at an early stage of infection
(Gama-Carvalho, M., R.D. Krauss, L. Chiang, J. Valcárcel, M.R. Green, and M. Carmo-Fonseca, unpublished results), splicing snRNPs are localized in nuclear speckles
that do not associate with sites of viral transcription and
splicing. After the onset of viral replication, at 14-18 h after infection, snRNPs redistribute from the speckles to
ring-like structures located at the periphery of the viral genomes and which have been shown to correspond to sites
of viral RNA synthesis (Pombo et al., 1994
). At later stages of infection (20-24 h after infection), snRNPs and splicing
factors are predominantly detected in large speckles that
contain spliced adenoviral RNA and represent enlarged
clusters of interchromatin granules (Bridge et al., 1993
,
1995, 1996; Puvion-Dutilleul et al., 1994
). Here we have
analyzed cells at intermediate stages of adenoviral infection when sites of active viral transcription and splicing
can be easily identified as ring structures, and we show
that U2AF65 colocalizes with splicing snRNPs in these
structures. Furthermore, upon treatment of infected cells
with transcription inhibitors, U2AF65 was predominantly
detected in speckles and not in ring structures, whereas after release of the drug, U2AF65 was again detected in rings
and not in speckles. This suggests that at intermediate
stages of infection adenovirus induces a recruitment of
U2AF65 from the nuclear speckles to sites of active splicing, and we have made use of this model system to test
whether deletion mutations that render U2AF65 unable to
support splicing in vitro also affect recruitment to spliceosomes in vivo. The results show that the U2AF65
RNP2,3
deletion mutant, which does not bind to pre-mRNA in
vitro (Zamore et al., 1992
), the U2AF65
84-150 mutant,
which has a deletion covering the region of interaction with U2AF35, and U2AF65
84-260, which has a deletion
spanning both the region of interaction with U2AF35 and
the RNP1 domain, are all recruited to the sites of viral splicing. In contrast, the U2AF65
RS mutant fails to concentrate in the ring structures that represent the sites of
adenoviral RNA synthesis. This raises the possibility that
in vivo the RS region of U2AF65 may be implicated in interactions that are sufficient to recruit the protein to sites
of active transcription and splicing, even in the absence of
RNA binding capacity.
.
1. Abbreviations used in this paper: CS, consensus sequence; RS, arginine/ serine; sn, small nuclear.We wish to acknowledge Professor David-Ferreira for support. We are also grateful to Mr. João Romão for animal care facilities, to Professors M. Lafarga and M.T. Berciano for testing mAb MC3 on cryosections from brain tissue, and to Dr. Fátima Almeida for help with microinjection experiments. We thank the following groups for generously providing materials used in this study: Professor A. Lamond, Dr. J. Mermoud, and Dr. K. Bohmann for SR protein extract, anti-coilin antibody 204, and poly (U) riboprobe; Dr. Eileen Bridge for adenoviruses, splice-junction probes, and anti-DBP antibodies; Professor Walther van Venrooij for anti-Sm autoimmune serum C45; Professor G. Dreyfuss for anti-hnRNP A1 antibody 4B10; and Prof. B. Turner for 3C5 antibody.
This study was supported by grants from Junta Nacional de Investigação Científica e Tecnológica /Program PRAXIS XXI. M. Gama-Carvalho was supported by a PRAXIS XXI research fellowship, and R. Krauss was the recipient of a post-doctoral fellowship from the American Cancer Society.